Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Clin Cancer Res. 2018 Dec 26;25(7):2314–2322. doi: 10.1158/1078-0432.CCR-18-2276

Figure 5. PEGPH20 treatment increased chemotherapy drug (paclitaxel) penetration to the tumor.

Figure 5.

Content of paclitaxel accumulated in the orthotopic tumor after PEGPH20 (n=3) or VEH treatment (n=3). *: P< 0.05 compared to the respective VEH group. Treatment/imaging schedules are the same as in Fig 1A.